Novo Gets Sanofi's Insulin Advertising Claims Trimmed
A New Jersey federal judge on Monday tossed Sanofi-Aventis' state consumer fraud law claim against Novo Nordisk over allegedly unlawful marketing of its competing diabetes medication, reasoning that the statute aims...To view the full article, register now.
Already a subscriber? Click here to view full article